Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors.
Craig B Stevens, James M Hanna, Robin K Lammi
Index: Bioorg. Med. Chem. Lett. 23(6) , 1703-6, (2013)
Full Text: HTML
Abstract
3,3',4,4'-Tetrahydroxybiphenyl and three isomeric 3,3″,4,4″-tetrahydroxyterphenyls with varying geometries around the central phenyl ring have been synthesized and evaluated for their in vitro activity against aggregation of Alzheimer's amyloid-β peptide (Aβ). Results from Congo red spectral-shift assays reveal that all four compounds successfully inhibit association of Aβ monomers. For the tetrahydroxyterphenyls, efficacy varies with linker geometry: the ortho-arrangement affords the most successful inhibition and the para-geometry the least, perhaps due to differing abilities of these compounds to bind Aβ. Of the four small molecules studied, 3,3',4,4'-tetrahydroxybiphenyl is the most effective inhibitor, reducing Aβ aggregation by 50% when present in stoichiometric concentrations.Copyright © 2013 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).
2012-02-15
[Bioorg. Med. Chem. 20 , 1388-95, (2012)]
2005-05-05
[J. Med. Chem. 48 , 3269-79, (2005)]
2008-04-01
[Eur. J. Med. Chem. 43 , 714-40, (2008)]
2015-01-01
[Anal. Bioanal. Chem 407(3) , 883-97, (2015)]
2014-06-01
[J. Pharm. Biomed. Anal. 94 , 203-9, (2014)]